Arfolitixorin clinical trials

A Clinical Study of Arfolitixorin in Patients With mCRC

This study is testing a new cancer medicine, arfolitixorin, for people with bowel cancer that has spread. It compares arfolitixorin to the usual treatment (leucovorin) to see if it's safer, works better, and to find the right dose alongside other standard medicines.